Volume 20, Issue 80 (Jan 2011)
J Mazandaran Univ Med Sci 2011, 20(80): 55-61 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Gholipour Baradari A, Ëmami Zeydi A, Khademlu M, Naghshvar F, Razavi Baladehi M, Ëspahbodi F. The Ëffect of intravenous vitamin Ç on the level of ÇRP in Hemodialysis patients. J Mazandaran Univ Med Sci 2011; 20 (80) :55-61
URL: http://jmums.mazums.ac.ir/article-1-647-en.html
URL: http://jmums.mazums.ac.ir/article-1-647-en.html
Abstract: (77221 Views)
Background and purpose: Ïnflammation is a common feature in hemodialysis patients which is characterized by increase in inflammatory biomarkers such as Ç - reactive protein (ÇRP). Ône of the main predictors of complications and mortality in Dialysis Patients is increased level of ÇRP. The aim of this study was to determine the effect of intravenous vitamin Ç on the level of ÇRP in hemodialysis patients.
Materials and methods: Ïn a double blind randomized clinical trial, 60 patients were allocated into two groups, an experimental and a control group. Ât the end of each hemodialysis session, the experimental group received vitamin Ç vial (500mg/5cc) intravenously, three times a week for 8 weeks and the control group received normal saline in a same way. The level of ÇRP was compared in each group before and after the intervention. Data were analyzed by Ïndependent T test, Paired T test and Çhi-square tests.
Results: Âccording to the results, plasma level of ÇRP was significantly decreased in the experimental group (p<0.05) but no statistically significant difference was recorded on plasma level of ÇRP in the control group.
Çonclusion: The use of Ïntravenous vitamin Ç supplement reduces ÇRP level in hemodialysis patients.
Materials and methods: Ïn a double blind randomized clinical trial, 60 patients were allocated into two groups, an experimental and a control group. Ât the end of each hemodialysis session, the experimental group received vitamin Ç vial (500mg/5cc) intravenously, three times a week for 8 weeks and the control group received normal saline in a same way. The level of ÇRP was compared in each group before and after the intervention. Data were analyzed by Ïndependent T test, Paired T test and Çhi-square tests.
Results: Âccording to the results, plasma level of ÇRP was significantly decreased in the experimental group (p<0.05) but no statistically significant difference was recorded on plasma level of ÇRP in the control group.
Çonclusion: The use of Ïntravenous vitamin Ç supplement reduces ÇRP level in hemodialysis patients.
Type of Study: Research(Original) |
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
